Pittsburgh Compound B

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Pittsburgh Compound B
Accession Number
DB15161
Description

Pittsburgh Compound B is under investigation in clinical trial NCT01723553 (Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD).

Type
Small Molecule
Groups
Investigational
Purchasing individual compounds or compound libraries for your research?
Learn More
Structure
Thumb
Weight
Average: 255.32
Monoisotopic: 255.078468006
Chemical Formula
C14H12N2OS
Synonyms
  • (N-methyl-(11C))2-(4'-methylaminophenyl)-6-hydroxybenzothiazole
  • 2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole
  • C-11 PiB

Pharmacology

Indication
Not Available
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Classification
Not classified

Chemical Identifiers

UNII
7P55415B0R
CAS number
566170-04-5
InChI Key
ZQAQXZBSGZUUNL-BJUDXGSMSA-N
InChI
InChI=1S/C14H12N2OS/c1-15-10-4-2-9(3-5-10)14-16-12-7-6-11(17)8-13(12)18-14/h2-8,15,17H,1H3/i1-1
IUPAC Name
2-{4-[(11C)methylamino]phenyl}-1,3-benzothiazol-6-ol
SMILES
[11CH3]NC1=CC=C(C=C1)C1=NC2=C(S1)C=C(O)C=C2

References

General References
Not Available
ChemSpider
2104829
ChEMBL
CHEMBL207456

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4Enrolling by InvitationDiagnosticAlzheimer's Disease (AD) / Dementia, Vascular / Diffuse Lewy Body Disease / Frontotemporal Dementia1
4Enrolling by InvitationDiagnosticDiffuse Lewy Body Disease1
2Active Not RecruitingDiagnosticAlzheimer's Disease (AD)1
2CompletedBasic ScienceAlzheimer's Disease (AD)1
2CompletedDiagnosticAlzheimer's Disease (AD)1
1CompletedBasic ScienceAlzheimer's Disease (AD)1
1CompletedDiagnosticAlzheimer's Disease (AD)1
1CompletedDiagnosticAphasia / Aphasia, Non-fluent / Apraxia of Speech / PPA / Primary Progressive Nonfluent Aphasia / Progressive Aphasia / Progressive Primary Aphasia / Semantic Dementia1
1CompletedDiagnosticAtypical Alzheimers Disease / Logopenic Variant of Primary Progressive Aphasia (LPA) / Posterior Cortical Atrophy (PCA)1
0CompletedBasic ScienceAlcohol Use Disorder (AUD)1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.0162 mg/mLALOGPS
logP4.11ALOGPS
logP3.31ChemAxon
logS-4.2ALOGPS
pKa (Strongest Acidic)9.23ChemAxon
pKa (Strongest Basic)3.65ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area45.15 Å2ChemAxon
Rotatable Bond Count2ChemAxon
Refractivity84.4 m3·mol-1ChemAxon
Polarizability28.12 Å3ChemAxon
Number of Rings3ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created on May 20, 2019 08:55 / Updated on June 12, 2020 10:53

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates